JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB97225

Goat Anti-Human IgG Fc (HRP)

Be the first to review this product! Submit a review

|

(78 Publications)

Goat anti-human IgG Fc (HRP) (ab97225) is a polyclonal horseradish peroxidase (HRP)-conjugated secondary antibody that reacts with the Fc portion of human IgG heavy chain. Suitable for ICC, IHC, western blot and ELISA applications.

- Flexible signal amplification- use in colorimetric or chemiluminescent detection
- Proven performance: cited in over 75 publications

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

Key facts

Host species

Goat

Target species

Human

Target isotype

IgG

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

HRP

Excitation/Emission
Applications

ICC, WB, ELISA, IHC-P

applications

Clonality

Polyclonal

Isotype

IgG

Specificity

By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgG. Cross reactivity with other IgM, IgA, and light chains is less than 1%. This antibody may cross react with IgG from other species.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/2000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/100000", "notes":"<p>(Primary)</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/2000 - 1/25000", "notes":"<p>Colormetric: 1/2000 - 1/20000; Chemiluminescent: 1/5000 - 1/25000</p>" } } }

Product details

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers a comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase (HRP).
Storage buffer
pH: 6.8 - 7.4 Constituents: PBS, 0.2% BSA, 0.05% CMIT/MIT based preservative
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Additional targets

IGHG2,IGHG3,IGHG4

Publications (78)

Recent publications for all applications. Explore the full list and refine your search

Biotechnology reports (Amsterdam, Netherlands) 48:e00917 PubMed41036080

2025

Solving the light chain mismatch of IgG-like bispecific antibody by utilizing 2A peptide based FaBody platform.

Applications

Unspecified application

Species

Unspecified reactive species

Dong Li,Pengfan Zheng,Xuejing Yao,Baopeng Zhang,Jiekun Zhang,Yaocheng Qu,Shasha Yun,Yanzhen Li,Shanshan Chen,Jianmin Fang

ImmunoTargets and therapy 14:979-995 PubMed40937368

2025

Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Carole Seguin-Devaux,Bianca Brandus,Jean-Marc Plesseria,Gilles Iserentant,Jean-Yves Servais,Aubin Pitiot,Georgia Kanli,Iris Behrmann,Rafaëla Schober,Jacques Zimmer,Jacques H M Cohen,Xavier Dervillez

Virology journal 22:275 PubMed40790492

2025

Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Li,Shaoyan Wang,Yue Cui,Liyuan Song,Zhenwei Song,Ping Huang,Xiangyang Chi,Ting Fang,Yunzhu Dong,Ruihua Li,Pengfei Fan,Yaoxing Wang,Lei Bi,Jianmin Li,Guanying Zhang,Changming Yu

Cancer immunology, immunotherapy : CII 74:231 PubMed40448719

2025

Cancer therapy via neoepitope-specific monoclonal antibody cocktails.

Applications

Unspecified application

Species

Unspecified reactive species

Colin J Hartman,Asmaa O Mohamed,Girja S Shukla,Stephanie C Pero,Yu-Jing Sun,Roberto S Rodríguez-Jimenez,Nicholas F Genovese,Nico M Kohler,Thomas R Hemphill,Yina H Huang,David N Krag,Margaret E Ackerman

Viruses 17: PubMed40285002

2025

Screening of Neutralizing Antibodies Targeting Gc Protein of RVFV.

Applications

Unspecified application

Species

Unspecified reactive species

Chuanyi Zhao,Meng Hao,Ting Bian,Xiaofan Zhao,Xiangyang Chi,Zhengshan Chen,Guangcheng Fu,Zheng Zhu,Ting Fang,Changming Yu,Jianmin Li,Wei Chen

Frontiers in pharmacology 16:1534048 PubMed40260388

2025

Ocular pharmacokinetics of intravitreal conbercept in a rabbit model following retinal scatter laser photocoagulation.

Applications

Unspecified application

Species

Unspecified reactive species

Lanlan Chen,Hua Liu,Qingrong Zhang,Houbin Huang

Frontiers in immunology 16:1543212 PubMed40213557

2025

Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao Yang,Xin Tang,Ying Sun,Hualong Xi,Wei Peng,Lu Yan,Wenjing Teng,Yang Zang,Chunlai Jiang

Cellular and molecular life sciences : CMLS 82:128 PubMed40128454

2025

The HBV large envelope protein initiates virion assembly by recruiting capsids at membrane rich domains related to late endosome.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Seigneuret,Sébastien Eymieux,Vanessa Sarabia-Vega,Roxane Lemoine,Julien Burlaud-Gaillard,Pierre Raynal,Christophe Hourioux,Camille Sureau,Philippe Roingeard,Hugues de Rocquigny

Frontiers in immunology 16:1530736 PubMed40034698

2025

Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Cenrong Wang,Xin Tang,Chenghan Jiang,Yu Zhang,Bo Han,Yi Sun,Jianfeng Guo,Hanyu Peng,Zihan Wang,Yipeng Wang,Jialu Zhang,Yong Zhang,Chunlai Jiang

Journal of nanobiotechnology 23:119 PubMed39966941

2025

Epitope-focused vaccine immunogens design using tailored horseshoe-shaped scaffold.

Applications

Unspecified application

Species

Unspecified reactive species

Fangxin Zhao,Yue Zhang,Zhiling Zhang,Zhengshan Chen,Xiaolin Wang,Shaoyan Wang,Ruihua Li,Yaohui Li,Zhang Zhang,Wanru Zheng,Yudong Wang,Zhe Zhang,Shipo Wu,Yilong Yang,Jun Zhang,Xiaodong Zai,Junjie Xu,Wei Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com